Never miss a Delaware County story!
ArriVent Biopharma in Newtown Square plans to initiate a public stock offering to raise between $137.5 million and $160 million for the development and…
Two Delaware County life science firms are leading the way this year in equity financing.
A cancer treatment drug being developed by ArriVent Biopharma in…
A Newtown Square biopharmaceutical company, ArriVent, has raised $110 million in a private stock sale to bring cancer medicines approved in China to the U…
Before we send you to this site, please subscribe to our daily newsletter.